4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-14-003736
EVP, DEVELOPMENT AND CMO sold 25,000 shares at $30.09 ($752,265)
- EVP, DEVELOPMENT AND CMO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mills Roger EVP, DEVELOPMENT AND CMO | 2014-11-26 | Option exercise | +25,000 | 43,550 | D | ||
| Mills Roger EVP, DEVELOPMENT AND CMO | 2014-11-26 | Sale | −25,000 | $30.09 | $752,265 | 18,550 | D |
| Derivatives | |||||||
| Mills Roger EVP, DEVELOPMENT AND CMO | 2014-11-26 | Option exercise · Stock Option (right to buy) | −25,000 | 139,035 | D | ||
| Open-market sales · 25,000 sh · avg $30.09 · $752,265 | |||||||
Loading xslF345X03/form4-11262014_031154.xml…